KMI169
KMI169 is a potent and selective bisubstrate inhibitor targeting KMT9's SAM and substrate binding pockets. KMT9 monomethylates histone H4 at lysine 12 and regulates the proliferation of prostate cancer cells. KMI169 can be utilized for research in prostate cancer.
Product Specifications
Field of Research
Epigenetics & Chromatin
Molecular Formula
C31H31Cl2N7O2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-0572R-Cy5.5 100 µL
Cyclin B1 Polyclonal Antibody, Cy5.5 Conjugated
Sign In for Pricing
View Details 
PC1021814-01 250 mg
1-methoxy-4- (3,3,3-trifluoroprop-1-en-2-yl) benzene
Sign In for Pricing
View Details